Literature DB >> 17386851

Mechanisms of cardiac hypertrophy.

Giulio Selvetella1, Giuseppe Lembo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 17386851     DOI： 10.1016/j.hfc.2005.03.006

Source DB:  PubMed          Journal:  Heart Fail Clin        ISSN： 1551-7136            Impact factor:   3.179


× No keyword cloud information.
  10 in total

1.  Vitexin protects against cardiac hypertrophy via inhibiting calcineurin and CaMKII signaling pathways.

Authors:  Cui-cui Lu; Ying-qi Xu; Ji-chao Wu; Peng-zhou Hang; Yan Wang; Chen Wang; Jian-wei Wu; Jian-cui Qi; Yong Zhang; Zhi-min Du
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-04-28       Impact factor: 3.000

Review 2.  Non-proliferative and Proliferative Lesions of the Cardiovascular System of the Rat and Mouse.

Authors:  Brian R Berridge; Vasanthi Mowat; Hirofumi Nagai; Abraham Nyska; Yoshimasa Okazaki; Peter J Clements; Matthias Rinke; Paul W Snyder; Michael C Boyle; Monique Y Wells
Journal:  J Toxicol Pathol       Date:  2016-07-29       Impact factor: 1.628

3.  Left ventricular geometry predicts cardiovascular outcomes associated with anemia correction in CKD.

Authors:  Kai-Uwe Eckardt; Armin Scherhag; Iain C Macdougall; Dimitrios Tsakiris; Naomi Clyne; Francesco Locatelli; Michael F Zaug; Hans U Burger; Tilman B Drueke
Journal:  J Am Soc Nephrol       Date:  2009-10-22       Impact factor: 10.121

4.  Protein kinase Cθ is required for cardiomyocyte survival and cardiac remodeling.

Authors:  R Paoletti; A Maffei; L Madaro; A Notte; E Stanganello; G Cifelli; P Carullo; M Molinaro; G Lembo; M Bouché
Journal:  Cell Death Dis       Date:  2010-05-27       Impact factor: 8.469

5.  Volume overload and adverse outcomes in chronic kidney disease: clinical observational and animal studies.

Authors:  Szu-Chun Hung; Yi-Shin Lai; Ko-Lin Kuo; Der-Cherng Tarng
Journal:  J Am Heart Assoc       Date:  2015-05-05       Impact factor: 5.501

6.  Estimated Glomerular Filtration Rate and Systolic Time Intervals in Risk Stratification for Increased Left Ventricular Mass Index and Left Ventricular Hypertrophy.

Authors:  Wen-Hsien Lee; Po-Chao Hsu; Chun-Yuan Chu; Szu-Chia Chen; Hung-Hao Lee; Meng-Kuang Lee; Chee-Siong Lee; Hsueh-Wei Yen; Tsung-Hsien Lin; Wen-Chol Voon; Wen-Ter Lai; Sheng-Hsiung Sheu; Ho-Ming Su
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

7.  Pathological cardiac remodeling occurs early in CKD mice from unilateral urinary obstruction, and is attenuated by Enalapril.

Authors:  Onju Ham; William Jin; Lei Lei; Hui Hui Huang; Kenji Tsuji; Ming Huang; Jason Roh; Anthony Rosenzweig; Hua A Jenny Lu
Journal:  Sci Rep       Date:  2018-10-31       Impact factor: 4.379

8.  Hypothalamic Norepinephrine Concentration and Heart Mass in Hypertensive ISIAH Rats Are Associated with a Genetic Locus on Chromosome 18.

Authors:  Olga E Redina; Svetlana E Smolenskaya; Yulia K Polityko; Nikita I Ershov; Michael A Gilinsky; Arcady L Markel
Journal:  J Pers Med       Date:  2021-01-23

Review 9.  Atrial Fibrillation in Chronic Kidney Disease: An Overview.

Authors:  Sai Gadde; Revanth Kalluru; Swathi Priya Cherukuri; Rahul Chikatimalla; Thejaswi Dasaradhan; Jancy Koneti
Journal:  Cureus       Date:  2022-08-07

Review 10.  Extracellular Vesicles in Cardiovascular Theranostics.

Authors:  Yihua Bei; Saumya Das; Rodosthenis S Rodosthenous; Paul Holvoet; Maarten Vanhaverbeke; Marta Chagas Monteiro; Valter Vinicius Silva Monteiro; Jana Radosinska; Monika Bartekova; Felix Jansen; Qian Li; Johnson Rajasingh; Junjie Xiao
Journal:  Theranostics       Date:  2017-09-26       Impact factor: 11.556
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.